Frequently Asked Questions relating to investing with ADVANZ PHARMA.
ADVANZ PHARMA's ticker symbols are ADVZ and ADVZ .U on the Toronto Stock Exchange (TSX).
The Investors page displays the current share price with a twenty minute delay.
Concordia started trading on the Toronto Stock Exchange on December 24, 2013.
ADVANZ PHARMA's CUSIP numbers are CA00775M1041 and US00775M3025.
ADVANZ PHARMA’s transfer agents are TSX Trust Company (Canada) and Continental Stock Transfer & Trust Company (US). The contact information for TSX Trust is email: email@example.com and phone: 1 866 393-4891. The contact information for Continental is email: firstname.lastname@example.org and phone: 1 212 509-4000.
ADVANZ PHARMA’s fiscal year end is December 31.
The next annual shareholder meeting has not yet been scheduled.
PricewaterhouseCoopers LLP is
ADVANZ PHARMA’s external auditor, to hold office until the next annual meeting of shareholders.
Not at this time.